These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 15658573

  • 1. Effects of terguride treatment on glucose abnormalities induced by ischemic brain damage in SHR/N-cp lean Koletsky strain and in rats of Wistar strain.
    Kudlackova Z, Golda V.
    Bratisl Lek Listy; 2004; 105(10-11):353-8. PubMed ID: 15658573
    [Abstract] [Full Text] [Related]

  • 2. Ambivalent effect of long lasting terguride treatment on genetically based glycide and lipid metabolism abnormalities in SHR/N-cp Koletsky rats.
    Golda V.
    Acta Medica (Hradec Kralove); 1998; 41(2):81-5. PubMed ID: 9729641
    [Abstract] [Full Text] [Related]

  • 3. Effect of long lasting terguride treatment on mutual relationship between glycide and lipid parameters in SHR/N-cp Koletsky rats.
    Golda V, Hilgertová J.
    Acta Medica (Hradec Kralove); 1998; 41(1):13-7. PubMed ID: 9588067
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Multiple regression analysis of parameters of lipid and glycide metabolism in obese and lean genetically hypertensive Koletsky rats under long lasting terguride treatment.
    Golda V, Hilgertová J.
    Acta Medica (Hradec Kralove); 1996; 39(4):141-7. PubMed ID: 9270120
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Hyperprolactinemia in obese as well as in lean females of Koletsky rats: effect of long lasting terguride treatment.
    Golda V, Jurcovicová J.
    Acta Medica (Hradec Kralove); 1998; 41(4):159-62. PubMed ID: 9951046
    [Abstract] [Full Text] [Related]

  • 9. Muscle GLUT-4 and insulin binding to erythrocytes and to adipose, liver and muscle tissue in genetically hypertensive obese rats and in their lean siblings: effect of long lasting terguride treatment.
    Golda V, Hilgertová J, Zórad S.
    Acta Medica (Hradec Kralove); 1998; 41(3):125-30. PubMed ID: 9919714
    [Abstract] [Full Text] [Related]

  • 10. Terguride attenuates prolactin levels and ameliorates insulin sensitivity and insulin binding in obese spontaneously hypertensive rats.
    Golda V, Ficková M, Pinterova L, Jurcovicová J, Macho L, Zórad S.
    Physiol Res; 2001; 50(2):175-82. PubMed ID: 11522045
    [Abstract] [Full Text] [Related]

  • 11. Characterization of the effects of the partial dopamine agonist terguride on cocaine self-administration in the rat.
    Pulvirenti L, Balducci C, Piercy M, Koob GF.
    J Pharmacol Exp Ther; 1998 Sep; 286(3):1231-8. PubMed ID: 9732383
    [Abstract] [Full Text] [Related]

  • 12. Pergolide, terguride and N,N'-spacer-linked oligomers of both interact with 5-HT2A receptors of rat tail artery.
    Kren V, Eich E, Pertz HH.
    Physiol Res; 2004 Sep; 53(1):35-43. PubMed ID: 14984312
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effect of dehydroepiandrosterone on lipemia, glucose tolerance, insulinemia, insulin binding to erythrocytes in SHR/N-cp lean rats of Koletsky type.
    Golda V, Hilgertová J.
    Acta Medica (Hradec Kralove); 1997 Sep; 40(2):31-5. PubMed ID: 9389208
    [Abstract] [Full Text] [Related]

  • 16. Effects of a partial D2-like receptor agonist on striatal dopamine autoreceptor functioning in preweanling rats.
    Yoshida ST, Baella SA, Stuebner NM, Crawford CA, McDougall SA.
    Brain Res; 2006 Feb 16; 1073-1074():269-75. PubMed ID: 16427034
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Pharmacological profile of 2-bromoterguride at human dopamine D2, porcine serotonin 5-hydroxytryptamine 2A, and α2C-adrenergic receptors, and its antipsychotic-like effects in rats.
    Jantschak F, Brosda J, Franke RT, Fink H, Möller D, Hübner H, Gmeiner P, Pertz HH.
    J Pharmacol Exp Ther; 2013 Oct 16; 347(1):57-68. PubMed ID: 23863695
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.